Genesco (GCO) Tops Q4 EPS by 34c, Offers FY21 Guidance
Get Alerts GCO Hot Sheet
Price: $34.55 -3.52%
EPS Growth %: +50.6%
Financial Fact:
Earnings (loss) from continuing operations: 25.95M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +50.6%
Financial Fact:
Earnings (loss) from continuing operations: 25.95M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Genesco (NYSE: GCO) reported Q4 EPS of $3.09, $0.34 better than the analyst estimate of $2.75. Revenue for the quarter came in at $678 million versus the consensus estimate of $679.7 million.
GUIDANCE:
Genesco sees FY2021 EPS of $4.90-$5.40, versus the consensus of $4.80.
- Total sales to increase 3% to 6% including sales from the recent Togast acquisition.
- Comparable sales to be down 1% to up 2%, and
- Adjusted diluted earnings per share from continuing operations in the range of $4.90 to $5.40 with an expectation that earnings for the year will be near the midpoint of the range. 2
For earnings history and earnings-related data on Genesco (GCO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Casey's General Stores (CASY) Tops Q1 EPS by 69c
- United Natural Foods (UNFI) Tops Q4 EPS by 8c ; Offers Guidance
- UBS upgrades Lockheed Martin to Buy, sees 26% upside on missile growth
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share